IC-411 2 Decades of Corneal Cross-Linking: Current Indications, Applications, Outcomes and Complications-Management; The US, FDA-Approved Technique and Evolving Technology and Techniques | ASCRS
Session
IC-411 2 Decades of Corneal Cross-Linking: Current Indications, Applications, Outcomes and Complications-Management; The US, FDA-Approved Technique and Evolving Technology and Techniques
April 2022
Meeting: 2022 ASCRS Annual Meeting
Course Instructors: Gregory Pamel, MD, A. John Kanellopoulos, MD, ABO
This content is only available for ASCRS Members

ASCRS Membership offers access to 1,000+ educational resources on demand.

Course Description
Didactic approach to the management of progressive cornea ectasia associated with keratoconus and refractive surgery. Several CXL treatment modalities and alternate techniques practiced internationally (epi-on, higher fluence-accelerated, and even refractive CXL) in order to halt ectasia, combined in some cases with a customised excimer laser ablation, intracorneal ring segments (ICRS) and/or phakic IOL to facilitate visual rehabilitation.

Educational Objective
The participants will share our vast experience of 2 decades, in managing progressive keratoconus and post-LASIK, PRK and Smile ectasia with CXL. Pearls on indications, patient selection, surgical technique and complication management for safe and effective results will be presented and discussed with the participants.

2022 ASCRS Annual Meeting Instructional Courses

This 1.5 hour Instructional Course was recorded at the 2022 ASCRS Annual Meeting in Washington, DC on April 22-25. 

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.